Impact of Self-Perceived Bothersomeness, Quality of Life and Overactive Bladder

  • Ja Hyeon Ku
  • Soo Woong Kim
Reference work entry


 Overactive bladder (OAB) is a condition characterized by urinary  urgency, with or without urge incontinence, urinary  frequency, and  nocturia. An estimated 10–20% of individuals living in the US and Europe have an OAB. Although an OAB is not a normal part of aging, its prevalence increases with age. The causes of OAB, as with many bladder disorders, are multifactorial and are not completely understood. Whereas the symptoms of an OAB are not life threatening, they may contribute to other disabling conditions and are clearly recognized to cause significant disruption and have significant adverse effects on the quality of life (QOL). Urgency is the principal symptom of an OAB and thus, assessing this symptom and its impact on the health-related QOL is important. Because an OAB and urinary incontinence in women are associated with sexual dysfunction, an evaluation of sexual function should be part of the routine examination of women who present with an OAB. An OAB can lead to coping behaviors that significantly affect patient well-being. In addition, patient-perceived irritating symptoms significantly influence the QOL in women with an OAB. Thus, future research should help identify the patients have irritating factors associated with an OAB. Since patients may regard their symptoms as embarrassing, untreatable or an inevitable part of getting older, they may not report OAB symptoms despite significant discomfort. It is therefore of utmost importance that medical education on the symptoms of an OAB and other related problems improve, to help health care professionals identify and treat patients who will benefit from therapy.


Urinary Incontinence Stress Urinary Incontinence Sexual Function Overactive Bladder Stress Incontinence 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

List of Abbreviations:

FV chart

 frequency-volume chart


King?′s health questionnaire


overactive bladder


overactive bladder questionnaire


quality of life


the medical outcomes study short form


  1. Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, van Kerrebroeck P, Victor A, Wein A; (2002). Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn. 21: 167–178.PubMedCrossRefGoogle Scholar
  2. Aslan G, Koseoglu H, Sadik O, GImen S, Cihan A, Esen A. (2005). Int J Impot Res. 17: 248–251.PubMedCrossRefGoogle Scholar
  3. Blaivas JG, Panagopoulos G, Weiss JP, Somaroo C, Chaikin DC. (2007). J Urol. 177: 199–202.PubMedCrossRefGoogle Scholar
  4. Bowden A, Colman S, Sabounjian L, Sandage B, Schwiderski U, Zayed H. (2003). Psychometric Validation of an Urgency Severity Scale (IUSS) for Patients with Overactive Bladder. Presented at the 33rd Annual Meeting of the International Continence Society. Florence, Italy.Google Scholar
  5. Brown JS, Posner SF, Stewart AL. (1999). J Am Geriatr Soc. 47: 980–988.PubMedGoogle Scholar
  6. Brown JS, Subak LL, Gras J, Brown BA, Kuppermann M, Posner SF. (1998). J Womens Health. 7: 1263–1269.PubMedCrossRefGoogle Scholar
  7. Button D, Roe B, Webb C, Frith T, Colin Thome D, Gardner L. (1998). Continence Promotion and Management by the Primary Health Care Team: Consensus Guidelines. Whurr Publishers Ltd, London.Google Scholar
  8. Cardozo L, Coyne KS, Versi E. (2005). BJU Int. 95: 591–596.PubMedCrossRefGoogle Scholar
  9. Chen GD, Lin TL, Hu SW, Lin TL, Lin LY. (2003). Neurourol Urodyn. 22: 109–117.PubMedCrossRefGoogle Scholar
  10. Coutts LC, Hardy LK. (1985). Teaching for Health. Churchill Livingstone, Edinburgh.Google Scholar
  11. Coyne K, Revicki D, Hunt T, Corey R, Stewart W, Bentkover J, Kurth H, Abrams P. (2002). Qual Life Res. 11: 563–574.PubMedCrossRefGoogle Scholar
  12. Coyne KS, Matza LS. (2002). Validation of the Perception of Bladder Condition Measure in Overactive Bladder. Presented at the 7th International Meeting of the International Society for Pharmacoeconomics and Outcomes Research. Arlington, VA, USA.Google Scholar
  13. Coyne KS, Payne C, Bhattacharyya SK, Revicki DA, Thompson C, Corey R, Hunt TL. (2004). Value Health. 7: 455–463.PubMedCrossRefGoogle Scholar
  14. Coyne KS, Zhou Z, Thompson C, Versi E. (2003). BJU Int. 92: 731–735.PubMedCrossRefGoogle Scholar
  15. Debeau CE, Kiely DK, Resnick NM. (1999). J Am Geriatr Soc. 47: 989–994.Google Scholar
  16. European Agency for the Evaluation of Medicinal Products and Committee for Proprietary Medicinal Products. (2002). Note for Guidance on the Clinical Investigation of Medicinal Products for the Treatment of Urinary Incontinence. London.Google Scholar
  17. Fultz NH, Burgio K, Diokno AC, Kinchen KS, Obenchain R, Bump RC. (2003). Am J Obstet Gynecol. 189: 1275–1282.PubMedCrossRefGoogle Scholar
  18. Gordon D, Groutz A, Sinai T, Wiezman A, Lessing JB, David MP, Aizenberg D. (1999). Int Urogynecol J Pelvic Floor Dysfunct. 10: 325–328.PubMedCrossRefGoogle Scholar
  19. Hannestad YS, Rortveit G, Sandvik H, Hunskaar S. (2000). J Clin Epidemiol. 53: 1150–1157.PubMedCrossRefGoogle Scholar
  20. Harrison GL, Memel DS. (1994). Br J Gen Pract. 44: 149–152.PubMedGoogle Scholar
  21. Homma Y, Yoshida M, Seki N, Yokoyama O, Kakizaki H, Gotoh M, Yamanishi T, Yamaguchi O, Takeda M, Nishizawa O. (2006). Urology. 68: 318–323.PubMedCrossRefGoogle Scholar
  22. Irwin DE, Milsom I, Hunskaar S, Reilly K, Kopp Z, Herschorn S, Coyne K, Kelleher C, Hampel C, Artibani W, Abrams P. (2006b). Eur Urol. 50: 1306–1314.PubMedCrossRefGoogle Scholar
  23. Irwin DE, Milsom I, Kopp Z, Abrams P, Cardozo L. (2006a). BJU Int. 97: 96–100.PubMedCrossRefGoogle Scholar
  24. Jeter KF, Wagner DB. (1990). J Am Geriatr Soc. 38: 379–383.PubMedGoogle Scholar
  25. Josephson KL, Ginsberg DA. (2004). Ann Long Term Care. 12: 25–32.Google Scholar
  26. Kelleher CJ, Cardozo LD, Khullar V, Salvatore S. (1997). Br J Obstet Gynaecol. 104: 1374–1379.PubMedCrossRefGoogle Scholar
  27. Kim YH, Seo JT, Yoon H. (2005). Int J Impot Res. 17: 158–163.PubMedCrossRefGoogle Scholar
  28. Kobelt G. (1997). Urology. 50(6A Suppl): 100–107.PubMedCrossRefGoogle Scholar
  29. Kobelt G, Kirchberger I, Malonee-Lee J. (1999). BJU Int. 83: 583–590.PubMedCrossRefGoogle Scholar
  30. Lapitan MC, Chye PL; (2001). Asia-Pacific Advisory Board. Int Urogynecol J Pelvic Floor Dysfunct. 12: 226–231.PubMedCrossRefGoogle Scholar
  31. Lenderking WR, Nackley JF, Anderson RB, Testa MA. (1996). Pharmacoeconomics. 9: 11–23.PubMedCrossRefGoogle Scholar
  32. Liberman JN, Hunt TL, Stewart WF, Wein A, Zhou Z, Herzog AR, Lipton RB, Diokno AC. (2001). Urology. 57: 1044–1050.PubMedCrossRefGoogle Scholar
  33. Lubeck DP, Prebil LA, Peeples P, Brown JS. (1999). Qual Life Res. 8: 337–344.PubMedCrossRefGoogle Scholar
  34. Matza LS, Thompson CL, Krasnow J, Brewster-Jordan J, Zyczynski T, Coyne KS. (2005). Neurourol Urodyn. 24: 215–225.PubMedCrossRefGoogle Scholar
  35. Miller J, Hoffman E. (2006). J Womens Health. 15: 251–260.CrossRefGoogle Scholar
  36. Milsom I, Abrams P, Cardozo L, Roberts RG, Thuroff J, Wein AJ. (2001). BJU Int. 87: 760–766.PubMedCrossRefGoogle Scholar
  37. Milsom I, Stewart W, Thuroff J. (2000). Am J Manag Care. 6(11 Suppl): S565–S573.PubMedGoogle Scholar
  38. Oh SJ, Ku JH. (2007). Urol Int 78: 63–69.PubMedCrossRefGoogle Scholar
  39. Papanicolaou S, Hunskaar S, Sykes D. (2005). BJU Int. 96: 831–838.PubMedCrossRefGoogle Scholar
  40. Renck-Hooper U, McKenna SP, Whalley D. (1997). J Outcomes Res. 1: 1–8.Google Scholar
  41. Robinson D, McClish DK, Wyman JF, Bump RC, Fanti JA. (1996). Neurourol Urodyn. 15: 143–148.PubMedCrossRefGoogle Scholar
  42. Sand PK, Goldberg RP, Dmochowski RR, McIlwain M, Dahl NV. (2006). Am J Obstet Gynecol. 195: 1730–1735.PubMedCrossRefGoogle Scholar
  43. Simeonova Z, Milsom I, Kullendorff AM, Molander U, Bengtsson C. (1999). Acta Obstet Gynecol Scand. 35: 546–551.CrossRefGoogle Scholar
  44. Stewart W, Herzog A, Wein A, Abrams P, Payne C, Corey R, Hunt T; (2001). NOBLE Program Research Team. Neurourol Urodyn. 20: 406–408.Google Scholar
  45. Stewart WF, Van Rooyen JB, Cundiff GW, Abrams P, Herzog AR, Corey R, Hunt TL, Wein AJ. (2003). World J Urol. 20: 327–336.PubMedGoogle Scholar
  46. Yip SK, Chan A, Pang S, Leung P, Tang C, Shek D, Chung T. (2003). Am J Obstet Gynecol. 188: 1244–1248.PubMedCrossRefGoogle Scholar
  47. Yu HJ, Wong WY, Chen J et al. (2003). Qual Life Res. 12: 327–333.PubMedCrossRefGoogle Scholar
  48. Zinner N, Harnett M, Sabounjian L, Sandage B Jr, Dmochowski R, Staskin D. (2005). J Urol. 173: 1639–1643.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media LLC 2010

Authors and Affiliations

  • Ja Hyeon Ku
  • Soo Woong Kim

There are no affiliations available

Personalised recommendations